Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma

Cancer

Volumn 117, Issue 1, 2011, Pages 197-206

  Cheuk, Daniel Ka Leung ^a   Billups, Catherine A ^a   Martin, Michael G ^a   Roland, Cynthia R ^a   Ribeiro, Raul C ^a   Krasin, Matthew J ^a   Rodriguez Galindo, Carlos ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

children; cumulative incidence; long term effects; nasopharyngeal carcinoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHILD; ETHNIC DIFFERENCE; EVENT FREE SURVIVAL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHYROIDISM; LONG TERM CARE; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NEGRO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 78650699631     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25376     Document Type: Article

References (44)

1. Ayan I, Altun M., Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys. 1996; 35: 485-492.
2. Ayan I, Kaytan E, Ayan N., Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol. 2003; 4: 13-21.
3. Vokes EE, Liebowitz DN, Weichselbaum RR., Nasopharyngeal carcinoma. Lancet. 1997; 350: 1087-1091.
4. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ,. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004; 22: 4604-4612.
5. Pao WJ, Hustu HO, Douglass EC, Beckford NS, Kun LE., Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. Int J Radiat Oncol Biol Phys. 1989; 17: 299-305.
6. Ghim TT, Briones M, Mason P, et al. Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: a final update of a long-term prospective study in a single institution. J Pediatr Hematol Oncol. 1998; 20: 131-135.
7. Lobo-Sanahuja F, Garcia I, Carranza A, Camacho A., Treatment and outcome of undifferentiated carcinoma of the nasopharynx in childhood: a 13-year experience. Med Pediatr Oncol. 1986; 14: 6-11.
8. Roper HP, Essex-Cater A, Marsden HB, Dixon PF, Campbell RH., Nasopharyngeal carcinoma in children. Pediatr Hematol Oncol. 1986; 3: 143-152.
9. Gasparini M, Lombardi F, Rottoli L, Ballerini E, Morandi F., Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children. J Clin Oncol. 1988; 6: 491-494.
10. Lombardi F, Gasparini M, Gianni C, De Marie M, Molinari R, Pilotti S., Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol. 1982; 10: 243-250.
11. Ayan I, Kaytan E, Ayan N,. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol. 2003; 4: 13-21.
12. Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G., Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft fur Padiatrische Onkologie und Hamatologie. Cancer. 1997; 80: 951-959.
13. Serin M, Erkal HS, Elhan AH, Cakmak A., Nasopharyngeal carcinoma in childhood and adolescence. Med Pediatr Oncol. 1998; 31: 498-505.
14. Wolden SL, Steinherz PG, Kraus DH, Zelefsky MJ, Pfister DG, Wollner N., Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2000; 46: 859-864.
15. Sahraoui S, Acharki A, Benider A, Bouras N, Kahlain A., Nasopharyngeal carcinoma in children under 15 years of age: a retrospective review of 65 patients. Ann Oncol. 1999; 10: 1499-1502.
16. Uzel O, Yoruk SO, Sahinler I, Turkan S, Okkan S., Nasopharyngeal carcinoma in childhood: long-term results of 32 patients. Radiother Oncol. 2001; 58: 137-141.
17. Zubizarreta PA, D'Antonio G, Raslawski E, et al. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy. Cancer. 2000; 89: 690-695.
18. Berberoglu S, Ilhan I, Cetindag F, Sunter O., Nasopharyngeal carcinoma in Turkish children: review of 33 cases. Pediatr Hematol Oncol. 2001; 18: 309-315.
19. Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL., Treatment results of 59 young patients with nasopharyngeal carcinoma. Int J Pediatr Otorhinolaryngol. 2005; 69: 201-207.
20. Kupeli S, Varan A, Ozyar E, et al. Treatment results of 84 patients with nasopharyngeal carcinoma in childhood. Pediatr Blood Cancer. 2006; 46: 454-458.
21. Ingersoll L, Woo SY, Donaldson S, et al. Nasopharyngeal carcinoma in the young: a combined M. D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys. 1990; 19: 881-887.
22. Cao KJ, Li Y, Xie GF, Hong MH., [Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence.] Zhonghua Zhong Liu Za Zhi. 2006; 28: 134-137.
23. Cao KJ, Li Y, Huang PY, Xie GF, Huang TB, Hong MH., [Long-term efficacy of radiotherapy on children with nasopharyngeal carcinoma.] Ai Zheng. 2004; 23: 1322-1324.
24. Bakkal BH, Kaya B, Berberoglu S, et al. The efficiency of different chemoradiotherapy regimens in patients with paediatric nasopharynx cancer: review of 46 cases. Int J Clin Pract. 2007; 61: 52-61.
25. Sheen JM, Yu HR, Huang EY, Wu KS, Wei SH, Hsiao CC., Nasopharyngeal carcinoma in children: a single institution's experience. Acta Paediatr Taiwan. 2005; 46: 268-271.
26. Sham JS, Poon YF, Wei WI, Choy D., Nasopharyngeal carcinoma in young patients. Cancer. 1990; 65: 2606-2610.
27. Daoud J, Toumi N, Bouaziz M, et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer. 2003; 39: 2349-2354.
28. Nakamura RA, Novaes PE, Antoneli CB, et al. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood. Cancer. 2005; 104: 525-531.
29. Haimi M, Arush MW, Bar-Sela G, et al. Nasopharyngeal carcinoma in the pediatric age group: the northern Israel (Rambam) medical center experience, 1989-2004. J Pediatr Hematol Oncol. 2005; 27: 510-516.
30. Green, FL, Page, DL, Fleming, ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. Philadelphia, Pa: Lippincott -Raven; 2002.
31. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977; 35: 1-39.
32. Kalbfleisch, JD, Prentice, RL,. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons; 1980.
33. Gray RJ., A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1141-1154.
34. Richey LM, Olshan AF, George J, et al. Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol Head Neck Surg. 2006; 132: 1035-1040.
35. Herrinton LJ., Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev. 1998; 20: 187-203.
36. Lim LH, Goh CH, Loong SL, Khin LW, Balakrishnan A, Wee J., Nasopharyngeal carcinoma in young patients. Int J Clin Pract. 2003; 57: 871-874.
37. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998; 16: 1310-1317.
38. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004; 101: 1584-1593.
39. Laskar S, Bahl G, Muckaden M, et al. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 72: 728-736.
40. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000; 18: 3339-3345.
41. Brizel DM, Overgaard J., Does amifostine have a role in chemoradiation treatment?; Lancet Oncol. 2003; 4: 378-381.
42. Orbach D, Brisse H, Helfre S, et al. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer. 2008; 50: 849-853.
43. Hui EP, Ma BB, Leung SF, et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 2009; 27: 242-249.
44. Straathof KCM, Bollard CM, Popat U, et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood. 2005; 105: 1898-1904.